Controversies concerning the use of phytoestrogens in menopause management: Bioavailability and metabolism

Maturitas

Volumn 65, Issue 4, 2010, Pages 334-339

  de Cremoux, Patricia ^a   This, Pascale ^a,b   Leclercq, Guy ^c   Jacquot, Yves ^d,e  

^a INSTITUT CURIE   (France)

^b CENTRE HOSPITALIER DE VERSAILLES   (France)

^c JULES BORDET INSTITUTE   (Belgium)

^d Centre National de la Recherche Scientifique   (France)

^e ECOLE NORMALE SUPÉRIEURE   (France)

Author keywords

Bioavailability; Menopause; Metabolism; Phytoestrogens

Indexed keywords

ESTRADIOL; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; ISOFLAVONE DERIVATIVE; LIGNAN DERIVATIVE; PHYTOESTROGEN;

BIOAVAILABILITY; ESTROGEN METABOLISM; HOT FLUSH; HUMAN; MENOPAUSAL SYNDROME; MENOPAUSE; REVIEW; WOMEN'S HEALTH;

EID: 77649180155     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2009.12.019     Document Type: Review

References (50)

1. This P., De La Rochefordiere A., Clough K., Fourquet A., and Magdelenat H. Phytoestrogens after breast cancer. Endocr Relat Cancer 8 2 (2001) 129-134
2. Bringer J., Raingeard I., Lefebvre P., and Renard E. Menopause: towards treatment "à la carte". Ann Endocrinol 64 4 (2003) 337-344
3. Wuttke W., Jarry H., Westphalen S., Christoffel V., and Sidlová-Wuttke D. Phytoestrogens for hormone replacement therapy?. J Steroid Biochem Mol Biol 83 1 (2003) 133-137
4. Kurzer M.S. Phytoestrogen supplement use by women. J Nutr 133 6 (2003) 1983S-1986S
5. Ziegler R.G. Phytoestrogens and breast cancer. Am J Clin Nutr 79 2 (2004) 183-184
6. Sirtori C.R., Arnoldi A., and Johnson S.K. Phytoestrogens: end of a tale?. Ann Med 37 6 (2005) 423-438
7. Boccardo F., Puntoni M., Gulielmini P., and Rubagotti A. Enterolactone as a risk factor for breast cancer: a review of the published evidence. Clin Chim Acta 365 1-2 (2006) 58-67
8. Wuttke W., Jarry H., and Sidlová-Wuttke D. Isoflavones-safe food additives or dangerous drugs?. Ageing Res Rev 6 2 (2007) 150-188
9. Velentzis L.S., Woodside J.V., Cantwell M.M., Leathem A.J., and Keshtgar M.R. Do phytoestrogen reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know. Eur J Cancer 44 13 (2008) 1799-1806
10. Crespy V., Morand C., Besson C., Manach C., Demigne C., and Remesy C. Quercetin, but not its glycosides, is absorbed from the rat stomach. J Agric Food Chem 50 3 (2002) 618-621
11. Piskula M.K., Yamakoshi J., and Iwai Y. Daidzein and genistein but not their glycosides are absorbed by the rat stomach. FEBS Lett 447 2 (1999) 287-291
12. Xu X., Wang H.J., Murphy P.A., Cook L., Hendrich S., and Daidzein. Is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 124 6 (1994) 825-832
13. Xu X., Harris K.S., Wang H.J., Murphy P.A., and Hendrich S. Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr 125 9 (1995) 2307-2315
14. Boulton D.W., Walle U.K., and Walle T. Extensive binding of the bioflavonoid quercetin to human plasma proteins. J Pharm Pharmacol 50 2 (1998) 243-249
15. Adlercreutz H., Bannwart C., Wähälä K., et al. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 44 2 (1993) 147-153
16. Brooks J.D., and Thompson L.U. Mammalian lignans and genistein decrease the activities of aromatase and 17β-hydroxysteroid dehydrogenase in MCF-7 cells. J Steroid Biochem Mol Biol 94 5 (2005) 461-467
17. Day A.J., Cañada F.J., Díaz J.C., et al. Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactate site of lactate phlorizin hydrolase. FEBS Lett 468 2 (2000) 166-170
18. Day A.J., DuPont M.S., Ridley S., et al. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β-glucosidase activity. FEBS Lett 436 1 (1998) 71-75
19. Hu M., Krausz K., Chen J., et al. Identification of CYP1A2 as the main isoform for the phase I hydroxylated metabolism of genistein and a prodrug converting enzyme of methylated isoflavones. Drug Metab Dispos 31 7 (2003) 924-931
20. Low Y.L., Taylor J.I., Grace P.B., et al. Polymorphisms in the CYP19 gene may affect the positive correlations between serum and urine phytoestrogen metabolites and plasma androgen concentrations in men. J Nutr 135 11 (2005) 2680-2686
21. Piller R., Verla-Tebit E., Wang-Gohrke S., Linseisen J., and Chang-Claude J. CYP17 genotype modifies the association between lignan supply and premenopausal breast cancer risk in humans. J Nutr 136 6 (2006) 1596-1603
22. Ayabe S.I., and Akashi T. Cytochrome P450s in flavonoid metabolism. Phytochem Rev 5 2-3 (2006) 271-282
23. Sangrajrang S., Sato Y., Sakamoto H., et al. Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women. Int J Cancer 125 4 (2009) 837-843
24. O'Leary K., Day A.J., Needs P.W., Mellon F.A., O'Brien N.M., and Williamson G. Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of β-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem Pharmacol 65 3 (2003) 479-491
25. Pasqualini J.R. Estrogen sulfotransferases in breast and endometrial cancers. Ann NY Acad Sci USA 1155 (2009) 88-98
26. Lee S.A., Choi J.Y., Shin C.S., Hong Y.C., Chung H., and Kang D. SULT1E1 genetic polymorphism modified the association between phytoestrogen consumption and bone mineral density in healthy Korean women. Calcif Tissue Int 79 3 (2006) 152-159
27. Pugazhendhi D., Watson K.A., Mills S., Botting N., Pope G.S., and Darbre P.D. Effect of sulphation on the oestrogen agonist activity of the phytoestrogens genistein and daidzein in MCF-7 human breast cancer cells. J Endocrinol 197 3 (2008) 503-515
28. Harris R.M., Wood D.M., Bottomley L., et al. Phytoestrogens are potent inhibitors of estrogen sulfation: implication for breast cancer risk and treatment. J Clin Endocrinol Metab 89 4 (2004) 1779-1787
29. Otake Y., Nolan A.L., Walle K., and Walle T. Quercetin and resveratrol potently reduce estrogen sulfotransferase activity in normal human mammary epithelial cells. J Steroid Biochem Mol Biol 73 5 (2000) 265-270
30. Chen Y., Chen S., Li X., Wang X., and Zeng S. Genetic variants of human UGT1A3: functional characterization and frequency distribution in a Chinese Han population. Drug Metab Disp 34 9 (2006) 1462-1467
31. Schneider H., and Blaut M. Anaerobic degradation of flavonoids by Eubacterium ramulus. Arch Microbiol 173 1 (2000) 71-75
32. Hur H.G., Lay Jr. J.O., Beger R.D., Freeman J.P., and Rafii F. Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin. Arch Microbiol 174 6 (2000) 422-428
33. Clavel T., Lippman R., Gavini F., Doré J., and Blaut M. Clostridium saccharogumia sp. Nov. and Lactonifactor longoviformis gen. Nov., sp. Nov., two novel human faecal bacteria involved in the conversion of the dietary phytoestrogen secoisolariciresinol diglucoside. Syst Appl Microbiol 30 1 (2007) 16-26
34. Yuan J.P., Wang J.H., and Liu X. Metabolism of dietary soy isoflavones to equol by human intestinal microflora-implications for health. Mol Nutr Food Res 51 7 (2007) 765-781
35. Hur H.G., and Rafii F. Biotransformation of the isoflavonoids biochanin A, formononetin, and glycitein by Eubacterium limosum. FEMS Microbiol Lett 192 1 (2000) 21-25
36. Jin J.S., Nishihata T., Kakiuchi N., and Hattori M. Biotransformation of C-glucosylisoflavone puerarin to estrogenic (3S)-equol in co-culture of two human intestinal bacteria. Biol Pharm Bull 31 8 (2008) 1621-1625
37. Raimondi S., Roncaglia L., De Lucia M., et al. Bioconversion of soy isoflavones daidzin and daidzein by Bifidobacterium strains. Appl Microbiol Biotechnol 81 5 (2009) 943-950
38. Jin J.S., Zhao Y.F., Nakamura N., Akao T., Kakiuchi N., and Hattori M. Isolation and characterization of a human intestinal bacterium, Eubacterium sp. ARC-2, capable of demethylating arctigenin, in the essential metabolic process to enterolactone. Biol Pharm Bull 30 5 (2007) 904-911
39. Clavel T., Henderson G., Alpert C.A., et al. Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans. Appl Environ Microbiol 71 10 (2005) 6077-6085
40. Jin J.S., Kakiuchi N., and Hattori M. Enantioselective oxidation of enterodiol to enterolactone by human intestinal bacteria. Biol Pharm Bull 30 11 (2007) 2204-2206
41. Wang X.L., Hur H.G., Lee J.H., Kim K.T., and Kim S.I. Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium. Appl Environ Microbiol 71 1 (2005) 214-219
42. Clavel T., Fallani M., Lepage P., et al. Isoflavones and functional foods alter dominant intestinal microbiota in postmenopausal women. J Nutr 135 12 (2005) 2786-2792
43. Kim K., Han J., and Kim S.U. Isoflavone daidzein: chemistry and bacterial metabolism. J Appl Biol Chem 51 (2008) 253-261
44. Wang X.L., Kim K.T., Lee J.H., Hur H.G., and Kim S.I. C-ring cleavage of isoflavones daidzein and genistein by a newly-isolated human intestinal bacterium Eubacterium ramulus Julong 601. J Microbiol Biotechnol 14 (2004) 766-771
45. Rowland I.R., Wiseman H., Sanders T.A.B., Adlercreutz H., and Bowey E.A. Interindividual variation in metabolism, of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 36 1 (2000) 27-32
46. Possemiers S., Bolca S., Eeckhaut E., Depypere H., and Verstraete W. Metabolism of isoflavones, lignans and prenylflavonoids by intestinal bacteria: producer phenotyping and relation with intestinal community. FEMS Microbiol Ecol 61 2 (2007) 372-383
47. Wang X.L., Kim H.J., Kang S.I., Kim S.I., and Hur H.G. Production of phytoestrogen S-equol from daidzein in mixed culture of two anaerobic bacteria. Arch Microbiol 187 2 (2007) 155-160
48. Setchell K.D., Brown N.M., and Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132 12 (2002) 3577-3584
49. Frankenfeld C.L., McTiernan A., and Thomas W.K. Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes. Maturitas 53 3 (2006) 315-324
50. Boniglia C., Carratu B., Gargiulo R., Giammarioli S., Mosca M., and Sanzini E. Content of phytoestrogens in soy-based dietary supplements. Food Chem 115 4 (2009) 1389-1392